Latest news
Loading news…
Tourmaline Bio is a biotechnology company that develops medicines to treat inflammatory and immune diseases in patients.
Tourmaline Bio was acquired by Novartis in 2025 for $1B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
32
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- New York, United States
Acquisitions by Tourmaline Bio
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Tourmaline Bio
Senior Vice President and Head of Commercial and Business Development
32
professional contacts at Tourmaline Bio
Contact execs at Tourmaline Bio →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Tourmaline Bio
Loading news…
FAQs about Tourmaline Bio
People who checked this page also checked these
Sectors Tourmaline Bio invests & acquires in
Browse the full Acquirezy directory.